Sankar, Anjali
Ozenne, Brice
Dam, Vibeke H.
Svarer, Claus http://orcid.org/0000-0001-7811-1825
Jørgensen, Martin B. http://orcid.org/0000-0002-1321-8901
Miskowiak, Kamilla W. http://orcid.org/0000-0003-2572-1384
Frokjaer, Vibe G.
Knudsen, Gitte M. http://orcid.org/0000-0003-1508-6866
Fisher, Patrick M. http://orcid.org/0000-0002-8115-0611
Funding for this research was provided by:
Innovationsfonden (4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B, 4108-00004B)
Lundbeckfonden (R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145, R279-2018-1145)
Article History
Received: 16 November 2022
Revised: 30 March 2023
Accepted: 19 April 2023
First Online: 11 May 2023
Competing interests
: GMK has received honoraria as expert advisor for Sanos and as a speaker for Sage Therapeutics and H Lundbeck. VGF has served as consultant for SAGE therapeutics and H. Lundbeck. All other authors declare no competing interests.